SynBioBeta Speaker
Bruce Schnicker
Pivot Bio
VP, Product Dev
Bruce Schnicker has joined Pivot Bio as vice president, product development. In this role, Bruce will be responsible for overseeing product development lifecycle from early-stage grower-oriented discovery to solution design and commercialization. Bruce will report to Travis Frey, chief technology officer. Schnicker comes to Pivot Bio from Bayer, where he led various organizations in the development and deployment of agricultural innovations spanning genetics, traits, crop management systems, and digital technologies across their R&D and Commercial platforms. His two plus decades of experience spans impact in over twenty crops and leading global teams across North, Central, and South America, Europe, Africa, Asia, Australia and New Zealand.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Bruce
This Year
•
-
Planetary Health
Rooted in Resilience: Speeding Up SynBio Plant Adaptation in a Rapidly Changing Climate
Climate volatility is reshaping the future of food, demanding plants that can withstand heat, drought, and disease. Synthetic biology offers powerful tools to accelerate adaptation—engineering plants with traits that once took decades to breed. This session explores how innovators are designing resilient plants, building platforms for rapid trait development, and forging collaborations across agtech, biotech, multinationals, and policy. Join us to hear how synbio is moving beyond the lab to the field, reshaping agriculture for resilience, and ensuring farmers worldwide can thrive in the face of climate uncertainty.
Get a Ticket
Featuring
Joshua Geilhufe
Rhiza Bio Cons.
Principal
First-market strategist for synbio agriculture and fermentation.
Lyle Ralston
Bayer Crop Science
CE Platform Lead
Engineering Crops for global food security
Joshua Armstrong
Corteva
IDD/BP Leader
Emily Hatas
Revive & Restore
Vice President
Bruce Schnicker
Pivot Bio
VP, Product Dev
Sowing the seeds for Biology's future
Michael Ferrari
Moby
VP, Head of Research
Data/AI “world-models” researcher bridging synbio to real markets.
•
-
Planetary Health
Rooted in Resilience: Speeding Up SynBio Plant Adaptation in a Rapidly Changing Climate
Climate volatility is reshaping the future of food, demanding plants that can withstand heat, drought, and disease. Synthetic biology offers powerful tools to accelerate adaptation—engineering plants with traits that once took decades to breed. This session explores how innovators are designing resilient plants, building platforms for rapid trait development, and forging collaborations across agtech, biotech, multinationals, and policy. Join us to hear how synbio is moving beyond the lab to the field, reshaping agriculture for resilience, and ensuring farmers worldwide can thrive in the face of climate uncertainty.
Get a Ticket
Featuring
Joshua Geilhufe
Rhiza Bio Cons.
Principal
First-market strategist for synbio agriculture and fermentation.
Lyle Ralston
Bayer Crop Science
CE Platform Lead
Engineering Crops for global food security
Joshua Armstrong
Corteva
IDD/BP Leader
Emily Hatas
Revive & Restore
Vice President
Bruce Schnicker
Pivot Bio
VP, Product Dev
Sowing the seeds for Biology's future
Michael Ferrari
Moby
VP, Head of Research
Data/AI “world-models” researcher bridging synbio to real markets.
Session lineup still growing
Get a Ticket
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Get a Ticket
Featuring
Speaker Coming Soon
